Holen Sie sich die Stockscreener-App
18.30
3.21%
0.57
Handel nachbörslich:
18.38
0.08
+0.44%
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Where are the Opportunities in (ASMB) - news.stocktradersdaily.com
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 47.1% in May - Defense World
Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034 - Precedence Research
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World
Assembly Biosciences expands stock plans, appoints new CFO By Investing.com - Investing.com Nigeria
Assembly Biosciences expands stock plans, appoints new CFO - Investing.com
Assembly Biosciences Announces Stock Plan Amendments and Leadership Change - TipRanks
Assembly Biosciences IncJeanette M. Bjorkquist Appointed Principal Financial Officer On June 5- SEC Filing - MarketScreener
(ASMB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Assembly Biosciences, Inc. (NASDAQ:ASMB) Shares Sold by Northern Trust Corp - Defense World
When Will Assembly Biosciences, Inc. (NASDAQ:ASMB) Breakeven? - Yahoo Finance
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Up 99.2% in May - Defense World
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference | ASMB Stock News - GuruFocus
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference - The Manila Times
Assembly Bio Leadership Team Set for Key Presentation at Major Jefferies Healthcare Conference - Stock Titan
Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics - Business Wire
Assembly’s NeosAI, Powered by Microsoft Azure AI Foundry, Sets New Benchmark for Legal Productivity—Backed by Real-World Results - GlobeNewswire Inc.
Mizuho Cuts Price Target on Assembly Biosciences to $29 From $36, Keeps Outperform Rating - marketscreener.com
ABI-4334 outperforms vebicorvir in HBV suppression - BioWorld MedTech
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Growth Investors: Industry Analysts Just Upgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue Forecasts By 33% - simplywall.st
Assembly Biosciences First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Zacks Research Cuts Earnings Estimates for Las Vegas Sands - Defense World
Assembly Biosciences: Q1 Earnings Snapshot - New Haven Register
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences Reports Q1 2025 Earnings - TipRanks
Assembly Biosciences Inc (ASMB) Q1 2025 Earnings: EPS of -$1.17 Beats Estimate, Revenue of $9.4M Exceeds Forecast - GuruFocus
Assembly Biosciences Updates on Clinical Progress and Financials, Anticipates Key Data in 2025 - Nasdaq
Assembly Biosciences (ASMB) Highlights Promising Preclinical Data at EASL Congress | ASMB Stock News - GuruFocus
New Preclinical Data for Assembly Biosciences' Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025 - The Manila Times
Ribbon Bio Launches MiroSynth™ DNA Molecules to Unlock a New Era of Complex Synthetic DNA - Yahoo Finance
Raymond James Financial Inc. Invests $973,000 in Invesco 0-5 Yr US TIPS ETF (BATS:PBTP) - The AM Reporter
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock? - NewsBreak: Local News & Alerts
Learn to Evaluate (ASMB) using the Charts - news.stocktradersdaily.com
JPMorgan Chase & Co. Acquires 7,918 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Assembly Biosciences Insiders Added US$679.4k Of Stock To Their Holdings - simplywall.st
Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Renaissance Technologies LLC Boosts Stock Holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Long Term Trading Analysis for (ASMB) - news.stocktradersdaily.com
Assembly Biosciences director sells $7,455 in stock - Investing.com Australia
Assembly Biosciences director sells $7,455 in stock By Investing.com - Investing.com South Africa
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK
Assembly Biosciences Presents New Data Highlighting Long-Acting - GuruFocus
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - The Manila Times
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Yahoo Finance
ASMB stock touches 52-week low at $8.21 amid market challenges - Investing.com
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):